I don't think there will be any upgrade at all. The stock price is well above almost all of the analyst reports anyway. On top of it, I think they lowered the next qtr numbers. What they were trying to justify is the the growth over last qtr might be sustained for few more years. The problem is that there is risk in that assumption, one more competition and hospitals that were planing to use them already done so and not that much more will use their services. One has to look back and see how revenue growth has gone up and down in the past years.